Home » Newsletters » BioWorld Science

BioWorld Science

March 16, 2001

View Archived Issues

Beta-amyloid peptide causes cognitive loss in AD via nicotinic receptor block

Id4 identified as regulator of BRCA1 expression

Novel cell-based transplantation therapy investigated for MS

NS-7 for both acute and chronic sequelae of cerebral ischemia

Initial results from pivotal trial of Cubist's Cidecin announced

Merck's second-generation HRT patch receives positive opinion in E.U.

Thrombin inhibition with PEG-hirudin as a new approach to the therapy of arthritis

XTL purchases stake in iviGene, gains access to technology

New safety information for miconazole vaginal cream and suppositories mandated by FDA

Beneficial effects of simvastatin independent of its cholesterol-lowering action

Argatroban enters phase II for ischemic stroke

XV-454 compares favorably to abciximab in flow models of thrombosis in vitro

Marketing application filed in Australia for PhotoCure's Metvix PDT

E.C. approves Rapamune for immunosuppression following renal transplantation

Bioenvision announces codevelopment partner for clofarabine

Pneumococcal vaccines claimed by Erasmus University

Modified erythropoietin with increased biological activity

Chymase-inhibitory thiazine and pyrazine derivatives under study at Santen

Potent and selective 5-ht6 receptor antagonists and their use described by NPS Allelix

Sumitomo presents new agents for immune and inflammatory disorders

Somatostatin receptor modulators designed at SCRAS

Draximage obtains license to infection imaging agent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...